Physician profile
Grady Hedstrom
NPI 1275945784
$50,267.26
in general payments reported to CMS, 2019-2025
15 companies · $6,031 in 2025
The $6,031 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $17K · 2023: $4,529 · 2024: $7,185 · 2025: $6,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,550 · Education: $5,000 · Consulting Fee: $2,900 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,615 · Travel and Lodging: $1,481 · Food and Beverage: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,550.00 |
| Education | $5,000.00 |
| Consulting Fee | $2,900.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,615.00 |
| Travel and Lodging | $1,480.71 |
| Food and Beverage | $1,198.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,099.10 | 2021-2022 | |
| Elucent Medical | $8,250.00 | 2024-2025 | |
| Intuitive Surgical, INC. | $8,153.39 | 2022-2025 | Ion, Da Vinci Surgical System |
| Medtronic, INC. | $1,763.18 | 2021-2024 | Illumisite |
| Pinnacle Biologics, INC | $536.94 | 2022 | |
| Ethicon INC. | $479.05 | 2021-2023 | Monarch Platform |
| Noah Medical Corporation | $375.00 | 2025 | Galaxy |
| Optellum LTD | $150.00 | 2025 | |
| Genentech USA, INC. | $125.16 | 2021 | |
| Olympus America INC. | $109.76 | 2023 | Spiration Valve System |
| Glaxosmithkline, LLC. | $60.28 | 2022 | |
| Imbio INC. | $56.50 | 2023 | Imbio Lung Density Analysis |
| Takeda Pharmaceuticals U.S.A., INC. | $46.22 | 2021-2022 | |
| Pulmonx Corporation | $38.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $24.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grady Hedstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.